Dupilumab
Sanofi,Regeneron
['eosinophilic,esophagitis', 'dupilumab']
dupilumab in adults and adolescents with eoe . 300mg weekly subcutaneous dupilumab improved histologic outcomes and alleviated symptoms of eoe. excellent study presented by dr. postgraduate course 
Associate Staff @ClevelandClinic | Alumni #IM @UMassIMResident | Aspiring Gastroenterologist | Views my own | RT≠ endorse | he/him.